Loading…

FIRST SALVAGE TREATMENT WITH BENDAMUSTINE AND BRENTUXIMAB VEDOTIN IN HODGKIN LYMPHOMA: A PHASE 2 STUDY OF FIL ONLUS

Saved in:

Bibliographic Details
Published in:	Hematological oncology 2019-06, Vol.37 (S2), p.296-296
Main Authors:	Stefoni, V., Broccoli, A., Botto, B., Corradini, P., Pinto, A., Re, A., Vitolo, U., Fanti, S., Argnani, L., Zinzani, P.
Format:	Article
Language:	English
Subjects:	Hodgkin's lymphoma Immunotherapy Lymphoma Monoclonal antibodies Salvage Targeted cancer therapy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by
cites
container_end_page	296
container_issue	S2
container_start_page	296
container_title	Hematological oncology
container_volume	37
creator	Stefoni, V. Broccoli, A. Botto, B. Corradini, P. Pinto, A. Re, A. Vitolo, U. Fanti, S. Argnani, L. Zinzani, P.
description
doi_str_mv	10.1002/hon.105_2630
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2242707236</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2242707236</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1110-b3835c96c2c0a0bb7c6c89277ee9d996c6c8254f3b92e82e7bad778010ed64f13</originalsourceid><addsrcrecordid>eNp9kE1Pg0AQhjdGE2v15g_YxKvo7FJY8LaVpRD5aApUe9oAXWKbWirYmP5711Q9mkwyH-8zM8mL0DWBOwJA71_brS4sSW0TTtCAgOsaBGz3FA2AMscAatJzdNH3awCtgTNAvR_OshxnPJrzicD5TPA8FkmOn8M8wGOReDwusjxMBOaJh8czrRUvYczHeC68VAtYR5B6kyedo0U8DdKYP2COpwHPBKY4ywtvgVMf-2GE0yQqskt01pSbXl395CEqfJE_BkaUTsJHHhk1IQSMynRMq3btmtZQQlWx2q4dlzKmlLt09Vy31Bo1ZuVS5VDFqnLJmAME1NIeNcQcopvj3V3Xvu9V_yHX7b7b6peS0hFlwKhpa-r2SNVd2_edauSuW72V3UESkN-2Sm2r_LVV49YR_1xt1OFfVgZp8rf3BW8ncJY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2242707236</pqid></control><display><type>article</type><title>FIRST SALVAGE TREATMENT WITH BENDAMUSTINE AND BRENTUXIMAB VEDOTIN IN HODGKIN LYMPHOMA: A PHASE 2 STUDY OF FIL ONLUS</title><source>Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)</source><creator>Stefoni, V. ; Broccoli, A. ; Botto, B. ; Corradini, P. ; Pinto, A. ; Re, A. ; Vitolo, U. ; Fanti, S. ; Argnani, L. ; Zinzani, P.</creator><creatorcontrib>Stefoni, V. ; Broccoli, A. ; Botto, B. ; Corradini, P. ; Pinto, A. ; Re, A. ; Vitolo, U. ; Fanti, S. ; Argnani, L. ; Zinzani, P.</creatorcontrib><identifier>ISSN: 0278-0232</identifier><identifier>EISSN: 1099-1069</identifier><identifier>DOI: 10.1002/hon.105_2630</identifier><language>eng</language><publisher>Chichester: Wiley Subscription Services, Inc</publisher><subject>Hodgkin's lymphoma ; Immunotherapy ; Lymphoma ; Monoclonal antibodies ; Salvage ; Targeted cancer therapy</subject><ispartof>Hematological oncology, 2019-06, Vol.37 (S2), p.296-296</ispartof><rights>2019 John Wiley & Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Stefoni, V.</creatorcontrib><creatorcontrib>Broccoli, A.</creatorcontrib><creatorcontrib>Botto, B.</creatorcontrib><creatorcontrib>Corradini, P.</creatorcontrib><creatorcontrib>Pinto, A.</creatorcontrib><creatorcontrib>Re, A.</creatorcontrib><creatorcontrib>Vitolo, U.</creatorcontrib><creatorcontrib>Fanti, S.</creatorcontrib><creatorcontrib>Argnani, L.</creatorcontrib><creatorcontrib>Zinzani, P.</creatorcontrib><title>FIRST SALVAGE TREATMENT WITH BENDAMUSTINE AND BRENTUXIMAB VEDOTIN IN HODGKIN LYMPHOMA: A PHASE 2 STUDY OF FIL ONLUS</title><title>Hematological oncology</title><subject>Hodgkin's lymphoma</subject><subject>Immunotherapy</subject><subject>Lymphoma</subject><subject>Monoclonal antibodies</subject><subject>Salvage</subject><subject>Targeted cancer therapy</subject><issn>0278-0232</issn><issn>1099-1069</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp9kE1Pg0AQhjdGE2v15g_YxKvo7FJY8LaVpRD5aApUe9oAXWKbWirYmP5711Q9mkwyH-8zM8mL0DWBOwJA71_brS4sSW0TTtCAgOsaBGz3FA2AMscAatJzdNH3awCtgTNAvR_OshxnPJrzicD5TPA8FkmOn8M8wGOReDwusjxMBOaJh8czrRUvYczHeC68VAtYR5B6kyedo0U8DdKYP2COpwHPBKY4ywtvgVMf-2GE0yQqskt01pSbXl395CEqfJE_BkaUTsJHHhk1IQSMynRMq3btmtZQQlWx2q4dlzKmlLt09Vy31Bo1ZuVS5VDFqnLJmAME1NIeNcQcopvj3V3Xvu9V_yHX7b7b6peS0hFlwKhpa-r2SNVd2_edauSuW72V3UESkN-2Sm2r_LVV49YR_1xt1OFfVgZp8rf3BW8ncJY</recordid><startdate>201906</startdate><enddate>201906</enddate><creator>Stefoni, V.</creator><creator>Broccoli, A.</creator><creator>Botto, B.</creator><creator>Corradini, P.</creator><creator>Pinto, A.</creator><creator>Re, A.</creator><creator>Vitolo, U.</creator><creator>Fanti, S.</creator><creator>Argnani, L.</creator><creator>Zinzani, P.</creator><general>Wiley Subscription Services, Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7QP</scope><scope>7T7</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>201906</creationdate><title>FIRST SALVAGE TREATMENT WITH BENDAMUSTINE AND BRENTUXIMAB VEDOTIN IN HODGKIN LYMPHOMA: A PHASE 2 STUDY OF FIL ONLUS</title><author>Stefoni, V. ; Broccoli, A. ; Botto, B. ; Corradini, P. ; Pinto, A. ; Re, A. ; Vitolo, U. ; Fanti, S. ; Argnani, L. ; Zinzani, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1110-b3835c96c2c0a0bb7c6c89277ee9d996c6c8254f3b92e82e7bad778010ed64f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Hodgkin's lymphoma</topic><topic>Immunotherapy</topic><topic>Lymphoma</topic><topic>Monoclonal antibodies</topic><topic>Salvage</topic><topic>Targeted cancer therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Stefoni, V.</creatorcontrib><creatorcontrib>Broccoli, A.</creatorcontrib><creatorcontrib>Botto, B.</creatorcontrib><creatorcontrib>Corradini, P.</creatorcontrib><creatorcontrib>Pinto, A.</creatorcontrib><creatorcontrib>Re, A.</creatorcontrib><creatorcontrib>Vitolo, U.</creatorcontrib><creatorcontrib>Fanti, S.</creatorcontrib><creatorcontrib>Argnani, L.</creatorcontrib><creatorcontrib>Zinzani, P.</creatorcontrib><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Hematological oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Stefoni, V.</au><au>Broccoli, A.</au><au>Botto, B.</au><au>Corradini, P.</au><au>Pinto, A.</au><au>Re, A.</au><au>Vitolo, U.</au><au>Fanti, S.</au><au>Argnani, L.</au><au>Zinzani, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>FIRST SALVAGE TREATMENT WITH BENDAMUSTINE AND BRENTUXIMAB VEDOTIN IN HODGKIN LYMPHOMA: A PHASE 2 STUDY OF FIL ONLUS</atitle><jtitle>Hematological oncology</jtitle><date>2019-06</date><risdate>2019</risdate><volume>37</volume><issue>S2</issue><spage>296</spage><epage>296</epage><pages>296-296</pages><issn>0278-0232</issn><eissn>1099-1069</eissn><cop>Chichester</cop><pub>Wiley Subscription Services, Inc</pub><doi>10.1002/hon.105_2630</doi><tpages>2</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0278-0232
ispartof	Hematological oncology, 2019-06, Vol.37 (S2), p.296-296
issn	0278-0232 1099-1069
language	eng
recordid	cdi_proquest_journals_2242707236
source	Wiley:Jisc Collections:Wiley Read and Publish Open Access 2024-2025 (reading list)
subjects	Hodgkin's lymphoma Immunotherapy Lymphoma Monoclonal antibodies Salvage Targeted cancer therapy
title	FIRST SALVAGE TREATMENT WITH BENDAMUSTINE AND BRENTUXIMAB VEDOTIN IN HODGKIN LYMPHOMA: A PHASE 2 STUDY OF FIL ONLUS
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T03%3A13%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=FIRST%20SALVAGE%20TREATMENT%20WITH%20BENDAMUSTINE%20AND%20BRENTUXIMAB%20VEDOTIN%20IN%20HODGKIN%20LYMPHOMA:%20A%20PHASE%202%20STUDY%20OF%20FIL%20ONLUS&rft.jtitle=Hematological%20oncology&rft.au=Stefoni,%20V.&rft.date=2019-06&rft.volume=37&rft.issue=S2&rft.spage=296&rft.epage=296&rft.pages=296-296&rft.issn=0278-0232&rft.eissn=1099-1069&rft_id=info:doi/10.1002/hon.105_2630&rft_dat=%3Cproquest_cross%3E2242707236%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1110-b3835c96c2c0a0bb7c6c89277ee9d996c6c8254f3b92e82e7bad778010ed64f13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2242707236&rft_id=info:pmid/&rfr_iscdi=true